B-lymphocyte-activating factor is a potential biomarker associated with susceptibility to Graves’ disease in Iraqi women
Abstract Background B-lymphocyte-activating factor (BAFF) is a cytokine involved in regulating the development and maturation of B lymphocyte and has been shown to be up-regulated in patients with Graves’ disease (GD). However, the association of TNFSF13B variants (the gene that encodes BAFF) with t...
Main Authors: | Hiba Y. Ibrahim, Ghassan M. Sulaiman, Ali H. Ad’hiah, Mohamed S. Al-shammaa |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-11-01
|
Series: | Egyptian Journal of Medical Human Genetics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43042-023-00455-5 |
Similar Items
-
Association of BAFF and BAFF-R polymorphisms with sarcoidosis in a Greek patient cohort
by: Maria Martinou, et al.
Published: (2022-10-01) -
The role of Lymphocytes Apoptosis in Grave's Disease Patients
by: Israa F. J. Al-Samaraee, et al.
Published: (2011-01-01) -
Low heterozygosity for rs3811050, a 5 prime untranslated region variant of the gene encoding interleukin-38 (IL1F10), is associated with a reduced risk of systemic lupus erythematosus
by: Rawan A. Nijeeb, et al.
Published: (2024-03-01) -
Neutrophil-to-Lymphocyte, Monocyte-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Relation to Clinical Parameters and Smoking Status in Patients with Graves’ Orbitopathy—Novel Insight into Old Tests
by: Joanna Szydełko, et al.
Published: (2020-09-01) -
Changes in the T and B lymphocyte subset profiles upon treatment of patients with Graves’ disease with radioactive iodine
by: A. A. Savchenko, et al.
Published: (2022-11-01)